Chromatin/Epigenetics

Epigenetics is the heritable modifications in gene expression that is not associated with changes in DNA sequence. Epigenetic modifications occur mostly on DNA or on the histone octamer. There are several types of epigenetics modifications, DNA methylation by DNA-methyl transferase (DNMT) and covalent modification of histones (e.g. acetylation, methylation, phosphorylation and ubiquitination). Histone acetylation by histone acetyltransferases (HATs) is involved in transcriptional activation, whereas histone deacetylation by histone deacetylases (HDACs) is connected with transcriptional repression. Histone demethylation is associated with lysine-specific demethylase (LSD) and JmjC domain containing histone demethylase (JHDM).
The nucleosome is consisted of four histone proteins (H2A, H2B, H3, and H4), they are primary building block of chromatin. The addition and removal of specific chemical groups refers to as epigenetic marks, it regulates chromatin structure and affects gene expression. Moreover, RNA is intimately involved in the formation of a repressive chromatin state.
Epigenetic mechanism responds to environmental changes at the cellular level and thus influences cellular plasticity. Chromatin and epigenetic regulation play a significant role in the programming of the genome during development and stress response, defects in epigenetics can lead to cancer, inflammation and metabolic disorders etc.
-   C3591 PTP Inhibitor IISummary: protein tyrosine phosphatase (PTP) inhibitor C3591 PTP Inhibitor IISummary: protein tyrosine phosphatase (PTP) inhibitor
-   C5162 BizineSummary: LSD1 inhibitor C5162 BizineSummary: LSD1 inhibitor
-   B4947 A 366Summary: G9a/GLP histone lysine methyltransferase inhibitor B4947 A 366Summary: G9a/GLP histone lysine methyltransferase inhibitor
-   A4129 ENMD-2076 L-(+)-Tartaric acidSummary: Aurora kinases inhibitor A4129 ENMD-2076 L-(+)-Tartaric acidSummary: Aurora kinases inhibitor
-   A4105 M3441 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,potent and cell-permeable A4105 M3441 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,potent and cell-permeable
-   A4147 LY2784544Target: Aurora Kinases|FLT3|VEGFR|FGFR|Trk Receptors|JAK|ALK|TYK2|MUSK|MAP3KSummary: JAK2 inhibitor,highly potent and selective A4147 LY2784544Target: Aurora Kinases|FLT3|VEGFR|FGFR|Trk Receptors|JAK|ALK|TYK2|MUSK|MAP3KSummary: JAK2 inhibitor,highly potent and selective
-   B6881 NSC 6632841 CitationSummary: Cdc25 dual specificity phosphatases inhibitor B6881 NSC 6632841 CitationSummary: Cdc25 dual specificity phosphatases inhibitor
-   A4531 WIKI4Summary: Inhibitor of Wnt/ß-Catenin signaling and tankyrase A4531 WIKI4Summary: Inhibitor of Wnt/ß-Catenin signaling and tankyrase
-   B5973 PFI 4Summary: Potent and selective BRPF1 Bromodomain inhibitor B5973 PFI 4Summary: Potent and selective BRPF1 Bromodomain inhibitor
-   C4247 RN-1 (hydrochloride)Summary: LSD1 inhibitor C4247 RN-1 (hydrochloride)Summary: LSD1 inhibitor
